Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)
Close on Nov 16, 2026Market cap $4.65BP/E –Yield –
Ionis Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Ionis Pharmaceuticals's total debt was $1.76B at Dec 31, 2025. For fiscal 2025 it was $1.76B, up 46.4% from the year before. Over ten years it grew 89.9% a year on average. The highest annual figure on record is $1.76B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | +46.4% |
| FY2024 | Dec 31, 2024 | $1.20B | -3.1% |
| FY2023 | Dec 31, 2023 | $1.24B | +5.6% |
| FY2022 | Dec 31, 2022 | $1.18B | +40.1% |
| FY2020 | Dec 31, 2020 | $839.57M | +6.6% |
| FY2019 | Dec 31, 2019 | $787.53M | +5627.9% |
| FY2018 | Dec 31, 2018 | $13.75M | +748.2% |
| FY2017 | Dec 31, 2017 | $1.62M | +36.8% |
| FY2016 | Dec 31, 2016 | $1.19M | +130.1% |
| FY2015 | Dec 31, 2015 | $515.00K | -82.1% |
| FY2014 | Dec 31, 2014 | $2.88M | -34.6% |
| FY2013 | Dec 31, 2013 | $4.41M | -9.7% |
| FY2012 | Dec 31, 2012 | $4.88M | -96.7% |
| FY2011 | Dec 31, 2011 | $148.96M | -3.5% |
| FY2010 | Dec 31, 2010 | $154.41M | +880.5% |
| FY2009 | Dec 31, 2009 | $15.75M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $1.76B | +109.6% |
| Q4 FY2024 | Dec 31, 2024 | $1.20B | +52.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.24B | +60150.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.18B | +8047.7% |
| Q4 FY2020 | Dec 31, 2020 | $839.57M | +5690.2% |
| Q4 FY2019 | Dec 31, 2019 | $787.53M | +5627.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.06M | +27.1% |
| Q2 FY2019 | Jun 30, 2019 | $14.43M | +1117.9% |
| Q1 FY2019 | Mar 31, 2019 | $14.50M | +29491.8% |
| Q4 FY2018 | Dec 31, 2018 | $13.75M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.19M | – |
| Q3 FY2016 | Sep 30, 2016 | $49.00K | – |
See a number that looks wrong?